A meta-analysis has previously reported an increased prevalence of DM in individuals with sarcopenia, attributed to factors such as obesity, physical inactivity, strict dietary practices, potential side effects of medications, accumulation of advanced glycation end products at the cellular level, and the lack of insulin's anabolic effects [22]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.